Viewing Study NCT05323435


Ignite Creation Date: 2025-12-24 @ 10:32 PM
Ignite Modification Date: 2025-12-25 @ 8:05 PM
Study NCT ID: NCT05323435
Status: COMPLETED
Last Update Posted: 2023-04-25
First Post: 2022-04-11
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Immunogenicity and Safety Study of Recombinant Two-Component COVID-19 Vaccine (CHO Cell)(ReCOV)
Sponsor: Jiangsu Rec-Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module